Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual […]
SUNNYVALE, Calif., July 02, 2024 (GLOBE NEWSWIRE) — News SummaryFortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of […]
TAMPA, Fla., July 02, 2024 (GLOBE NEWSWIRE) — Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical […]